Meeting
2020 ASCO Virtual Scientific Program
Clinical, radiologic & prognostic profile of IDH wild type diffuse astrocytic glioma with molecular features of glioblastoma.
Authors
Oluwatosin Akintola
MGH/DFCI/BWH/HMS, Boston
Oluwatosin Akintola , Wesley Samore , Maria Martinez-Lage Alvarez , Elizabeth Robins Gerstner
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 38: 2020 (suppl; abstr 2557)
DOI
10.1200/JCO.2020.38.15_suppl.2557
Abstract #
2557
Poster Bd #
48
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Malignant glioma subset from Actuate 1801: A phase 1/2 study of 9-ING-41, a glycogen synthase kinase 3 beta (GSK-3β) inhibitor, as a single agent and combined with chemotherapy, in patients with refractory hematologic malignancies or solid tumors.
First Author: Yazmin Odia
Poster
2019 ASCO Annual Meeting
Detection of targetable somatic alterations in glioblastoma (GBM) and clinical impact.
First Author: Michael Fusco
Poster
2018 ASCO Annual Meeting
Differential elevation of TERT activity and sensitivity to temozolomide by type of TERT mutation in MGMT promoter-methylated glioblastoma.
First Author: Michael Weller
Poster
2015 ASCO Annual Meeting
Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
First Author: Alissa A. Thomas